{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T02:27:46Z","timestamp":1775356066061,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.urolonc.2025.03.022","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:20:47Z","timestamp":1745248847000},"page":"470.e1-470.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer\u2010specific survival after surgery in patients with renal cell carcinoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Giacomo","family":"Musso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret F.","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kit L.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Ahdoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruv","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Dabbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Birouty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Saitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melis","family":"Guer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dattatraya","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Capitanio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viraj","family":"Master","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-0711","authenticated-orcid":false,"given":"Ithaar H.","family":"Derweesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10021","key":"10.1016\/j.urolonc.2025.03.022_bib0001","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","article-title":"Renal cancer","volume":"387","author":"Capitanio","year":"2016","journal-title":"The Lancet"},{"issue":"12","key":"10.1016\/j.urolonc.2025.03.022_bib0002","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.urolonc.2025.03.022_bib0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cncr.23518","article-title":"Renal cell cancer stage migration: analysis of the National Cancer Data Base","volume":"113","author":"Kane","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2025.03.022_bib0004","unstructured":"Ljungberg B, Bex A, Albiges L, et al. EAU Guidelines on Renal Cell Carcinoma 2024. Arnhem, The Netherlands: European Association of Urology; 2024. Available at: https:\/\/uroweb.org\/guidelines\/renal-cell-carcinoma."},{"issue":"4","key":"10.1016\/j.urolonc.2025.03.022_bib0005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/bju.15872","article-title":"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses","volume":"131","author":"Capitanio","year":"2023","journal-title":"BJU Int"},{"issue":"9","key":"10.1016\/j.urolonc.2025.03.022_bib0006","doi-asserted-by":"crossref","first-page":"392.e11","DOI":"10.1016\/j.urolonc.2023.06.015","article-title":"Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma","volume":"41","author":"Moldovan","year":"2023","journal-title":"Urolog Oncol"},{"key":"10.1016\/j.urolonc.2025.03.022_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.995991","article-title":"Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: a multicenter analysis","volume":"12","author":"Keiner","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.03.022_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102098","article-title":"Association of elevated C-reactive protein with worsened outcomes in different histologies of renal cortical tumors: analysis of the INMARC registry","volume":"22","author":"Saitta","year":"2024","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2025.03.022_bib0009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00432-019-03042-7","article-title":"The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma","volume":"146","author":"Kang","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2025.03.022_bib0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.03.022_bib0011","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/cncr.11851","article-title":"Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma","volume":"98","author":"Leibovich","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2025.03.022_bib0012","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.juro.2011.07.034","article-title":"External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology","volume":"186","author":"Pichler","year":"2011","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.03.022_bib0013","article-title":"Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: results from Canadian Kidney Cancer information system","volume":"15","author":"Sun","year":"2020","journal-title":"Canad Urologi Associat J"},{"key":"10.1016\/j.urolonc.2025.03.022_bib0014","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.2147\/OTT.S108469","article-title":"Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.urolonc.2025.03.022_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12894-024-01635-0","article-title":"The prognostic value of visible hematuria is only significant in T1a renal cell carcinoma: a single-center retrospective study","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.03.022_bib0016","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/bjc.2012.565","article-title":"Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma","volume":"108","author":"Choi","year":"2013","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2025.03.022_bib0017","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/cancers15082212","article-title":"Inflammatory networks in renal cell carcinoma","volume":"15","author":"Kruk","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.urolonc.2025.03.022_bib0018","doi-asserted-by":"crossref","DOI":"10.4081\/oncol.2019.413","article-title":"Thrombocytopenia in solid tumors: prognostic significance","volume":"13","author":"Ghanavat","year":"2019","journal-title":"Oncol Rev"},{"issue":"6","key":"10.1016\/j.urolonc.2025.03.022_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102207","article-title":"Paraneoplastic syndrome prevalence and survival in racially-diverse cohort with renal cell carcinoma","volume":"22","author":"Nicaise","year":"2024","journal-title":"Clin Genitourin Cancer"},{"issue":"Supplement_1","key":"10.1016\/j.urolonc.2025.03.022_bib0020","doi-asserted-by":"crossref","first-page":"A210","DOI":"10.1210\/jendso\/bvab048.428","article-title":"Paraneoplastic hypercalcemia as the initial presenting sign of metastatic renal cell carcinoma","volume":"5","author":"Gaballa","year":"2021","journal-title":"J Endocr Soc"},{"issue":"5","key":"10.1016\/j.urolonc.2025.03.022_bib0021","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner","year":"2016","journal-title":"J Oncol Pract"},{"issue":"6","key":"10.1016\/j.urolonc.2025.03.022_bib0022","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"JNCI"},{"issue":"2","key":"10.1016\/j.urolonc.2025.03.022_bib0023","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1590\/s1677-5538.ibju.2017.0173","article-title":"The effect of AST\/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma","volume":"44","author":"Canat","year":"2018","journal-title":"Int Braz J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2025.03.022_bib0024","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:06:34Z","timestamp":1752602794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392500122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S107814392500122X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.03.022","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer\u2010specific survival after surgery in patients with renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}